Characterization of putative 5-HT7 receptors mediating tachycardia in the cat

British Journal of Pharmacology

Volumn 121, Issue 6, 1997, Pages 1187-1195

  Villalón, Carlos M ^a,b   Heiligers, Jan P C ^a   Centurión, David ^b   De Vries, Peter ^a   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

5 HT (5 hydroxytryptamine); 5 HT7 receptors; 5 hydroxytryptamine receptors; Heart rate; Tachycardia

Indexed keywords

5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; CISAPRIDE; CLOZAPINE; ERGOTAMINE; INDORENATE; LISURIDE; MESULERGINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN RECEPTOR; SUMATRIPTAN; TROPISETRON; TRYPTAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CAT; DRUG ANTAGONISM; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA;

5-METHOXYTRYPTAMINE; ANIMALS; BLOOD PRESSURE; CATS; CISAPRIDE; DECEREBRATE STATE; HEART RATE; PIPERIDINES; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN; TACHYCARDIA;

EID: 0030786504     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701260     Document Type: Article

References (37)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 90, 408-412.
2. 7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 23422-23426.
3. CARTER, D., CHAMPNEY, M., HWANG, B. & EGLEN, R.M. (1995). Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol., 280, 243-250.
4. CONNOR, H.E. FENIUK, W., HUMPHREY, P.P.A. & PERREN, M.J. (1986). 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br. J. Pharmacol., 87, 417-426.
5. 1D receptor antagonist. Br. J. Pharmacol., 118, 85-92.
6. 7 receptor. Naunyn-Schmiedeberg's Arch. Pharmacol., (in press).
7. 1D, receptor subtypes. Trends Pharmacol. Sci., 17, 103-105.
8. 1 recognition sites. J. Receptor Res., 8, 59-81.
9. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
10. 7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br. J. Pharmacol., 117, 926-930.
11. LEYSEN, J.E. (1985). Serotonin binding sites. In Serotonin and the Cardiovascular System. ed. Vanhoutte, P.M. pp. 43-62. New York: Raven Press.
12. 7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449-458.
13. MARTIN, G.R. (1994). Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol. Ther., 62, 283-324.
14. 7 receptor? Br. J. Pharmacol., 114, 383P.
15. PLASSAT, J.L., AMLAIKY, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229-236.
16. RAND, M.J., MAJEWSKI, H., WONG-DUSTING, H., STORY, D.F., LOIACONO, R.E. & ZIOGAS, J. (1987). Modulation of neuroeffector transmission. J. Cardiovasc. Pharmacol., 10 (Suppl. 12), S33-S44.
17. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 8547-8551.
18. SAXENA, P.R. (1985). An interactive computer program for data management and parametric and non-parametric statistical analysis. Br. J. Pharmacol., 86, 818P.
19. SAXENA, P.R. (1986). Nature of the 5-hydroxytryptamine receptors in mammalian heart. Prog. Pharmacol., 6, 173-185.
20. 1-like receptors mediating tachycardia in the cat: no apparent relationship to known subtypes of the 5-hydroxytryptamine, binding site. Drug Develop. Res., 13, 245-258.
21. 1 receptors. Arch. Int. Pharmacodyn., 277, 235-252.
22. 1-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 330, 121-129.
23. SAXENA, P.R. & VILLALÓN, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15 (Suppl. 7), S17-S34.
24. SAXENA, P.R. & VILLALÓN, C.M. (1991). 5-Hydroxytryptamine, a chameleon in the heart. Trends Pharmacol. Sci., 12, 223-227.
25. 7 serotonin receptor subtype. J. Biol. Chem., 268, 18200-18204.
26. 1D receptor antagonist. Behav. Brain Res., 73, 157-161.
27. SUMNER, M.J., FENIUK, W. & HUMPHREY, P.P.A. (1989). Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br. J. Pharmacol., 97, 292-300.
28. 1 receptor-induced smooth muscle contraction in dog saphenous vein. Br. J. Pharmacol., 105, 603-608.
29. 7 receptor subtype. Br. J. Pharmacol., 118, 1421-1428.
30. TREVETHICK, M.A., FENIUK, W. & HUMPHREY, P.P.A. (1986). 5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in isolated neonatal porcine vena cava. Life Sci., 38, 1521-1528.
31. 1D receptor subtype. Eur. J. Pharmacol. 190, 167-176.
32. 7 receptor. Br. J. Pharmacol., 120, 1319-1327.
33. 4 receptor. Br. J. Pharmacol., 100, 665-667.
34. 4 receptor mediating tachycardia in the pig. Br. J. Pharmacol., 102, 107-112.
35. 1D receptor subtype. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 550-556.
36. 1D subtype. Br. J. Pharmacol., 113, 13-20.
37. 1-like receptors mediating the increase in external carotid blood flow in the dog. Drug Develop. Res., 29, 271-281.